Close  
  • share this

Allergan, Pfizer call off proposed $160B merger

/ 07:13 PM April 06, 2016
FILE - In this Nov. 23, 2015, file photo, the Allergan logo appears above a trading post on the floor of the New York Stock Exchange. Allergan and Pfizer called off Wednesday, April 6, 2016, a record $160 billion merger after the Treasury issued new rules to make "tax inversions" less lucrative. (AP Photo/Richard Drew, File)

In this Nov. 23, 2015, file photo, the Allergan logo appears above a trading post on the floor of the New York Stock Exchange. AP 

NEW YORK — Allergan and Pfizer are calling off a record $160 billion merger after the Treasury issued new rules to make “tax inversions” less lucrative.

The aggressive changes to U.S. tax laws announced this week helped to kill the deal. The merger would have moved Pfizer’s address — but not its operations or headquarters — to Ireland where it would pay far less in corporate taxes.

ADVERTISEMENT

Pfizer Inc., based in New York, has agreed to pay Allergan PLC $150 million for reimbursement of expenses.

FEATURED STORIES
Read Next
LATEST STORIES
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Allergan, Business, merger, pfizer, tax inversion
For feedback, complaints, or inquiries, contact us.



© Copyright 1997-2019 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.